Preferred Label : adenosine monophosphate;
MeSH definition : Adenine nucleotide containing one phosphate group esterified to the sugar moiety in
the 2'-, 3'-, or 5'-position.;
MeSH synonym : AMP;
CISMeF synonym : adenosine phosphate;
MeSH hyponym : 5'-Adenylic acid; adenosine phosphate disodium; adenosine 3'-Phosphate; 2'-adenylic acid; adenosine 2'-Phosphate; adenosine 5'-Phosphate; phosphaden; adenosine phosphate dipotassium; 5'-Phosphate, Adenosine; Adenosine 5' Phosphate; Dipotassium, Adenosine Phosphate; Phosphate Dipotassium, Adenosine; Disodium, Adenosine Phosphate; Phosphate Disodium, Adenosine; Adenosine 2' Phosphate; 2' Adenylic Acid; Acid, 2'-Adenylic; 2'-Adenosine Monophosphate; 2' Adenosine Monophosphate; Monophosphate, 2'-Adenosine; Adenylic Acid; 2'-AMP; 5' Adenylic Acid; Acid, 5'-Adenylic; Adenosine 3' Phosphate;
MeSH CAS label : 5'-Adenylic acid;
MeSH Related Number : 61-19-8 (Adenosine monophosphate); adenosine phosphate dipotassium; adenosine phosphate disodium; 2'-Adenylic acid; 130-49-4; 225M14T7DD; T1WZ11DSRN;
Registry Number MeSH : 61-19-8;
Related CAS MeSH : 225M14T7DD (Adenosine phosphate dipotassium); T1WZ11DSRN (Adenosine phosphate disodium); 130-49-4 (2'-Adenylic acid);
MeSH annotation : /biosyn /physiol permitted;
Wikipedia link : https://en.wikipedia.org/wiki/Adenosine monophosphate;
Codes EINECS : 200-500-0;
Is substance : O;
UNII : 415SHH325A;
InChIKey : UDMBCSSLTHHNCD-KQYNXXCUSA-N;
Origin ID : D000249;
UMLS CUI : C0001465;
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
False automatic mappings
Record concept(s)
Related MeSH Supplementary Concept(s)
- cf 1001 [MeSH Supplementary Concept]
- cf 1093 [MeSH Supplementary Concept]
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT
Adenine nucleotide containing one phosphate group esterified to the sugar moiety in
the 2'-, 3'-, or 5'-position.
https://pgtmsite.files.wordpress.com/2024/01/ad_covid-ambulatoire-pediatrie_vf2_20230405.pdf
https://pgtmsite.files.wordpress.com/2024/01/poster_covid-adulte-et-ped_apes_-2023_final-1.pdf
2023
false
false
false
Canada
antibodies, monoclonal, humanized
antibodies, neutralizing
alanine
adenosine monophosphate
ribonucleotides
pediatrics
alanine
adenosine monophosphate
ribonucleotides
guidelines for drug use
remdesivir
sotrovimab
outpatients
hospitals, university
COVID-19
quebec
---
https://sante.gouv.fr//systeme-de-sante-et-medico-social/acces-origines-AMP/
2022
France
popular works
reproductive techniques, assisted
medical assistant
adenosine monophosphate
persons
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1196
2022
France
public health guidelines
reproductive techniques, assisted
Dengue
helper viruses
zika virus
medical assistant
Zika Virus
Virus
Dengue fevers
risk assessment
dengue virus
measures
dengue virus, nos
relative risk
adenosine monophosphate
Viruses
judgment
---
https://dumas.ccsd.cnrs.fr/dumas-03368329
2021
France
dissertations, academic
mobile applications
comprehension
has patient
critical pathways
education, medical
Applications
Applications
understanding, nos
adenosine monophosphate
mobility, nos
Applications
patient satisfaction
---
https://presse.inserm.fr/absence-defficacite-du-remdesivir-chez-les-patients-hospitalises-atteints-de-covid-19-et-poursuite-de-lessai-discovery-pour-tester-un-nouveau-medicament-antiviral/43790
2021
false
false
false
France
French
journal article
coronavirus infections
alanine
alanine
ribonucleotides
adenosine monophosphate
adenosine monophosphate
COVID-19
treatment outcome
remdesivir
antiviral agents
medical futility
Lack of drug action (finding)
inpatients
---
https://www.cochrane.org/fr/CD014962/HAEMATOL_remdesivir-dans-le-traitement-des-personnes-atteintes-de-la-covid-19
2021
false
false
false
France
United Kingdom
COVID-19
adenosine monophosphate
alanine
antiviral agents
review of literature
french abstract
remdesivir
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1077
2021
France
COVID-19
public health guidelines
reproductive techniques, assisted
SARS-CoV-2
measures
virus, nos
risk assessment
viruses
medical assistant
adenosine monophosphate
Virus
Severe acute respiratory syndrome-related coronavirus
Viruses
risk
weights and measures
viruses
risk
Betacoronavirus
---
https://www.agence-biomedecine.fr/IMG/pdf/2018-003_reco_amp_et_zika_v5_09-02-2018_.pdf
2018
false
false
false
false
France
French
consensus
Zika Virus Infection
circulating
zika virus
france
condom
french
gift giving
patient care management
directed tissue donation
americas
adenosine monophosphate
medical assistant
viruses
fertility preservation
fertility, nos
gametes
gift giving
adenosine monophosphate
germ cells
---
https://www.ccne-ethique.fr/node/177?taxo=0
2017
false
false
false
France
French
guidelines
adenosine monophosphate
medical assistant
judgment
reproductive techniques, assisted
adenosine monophosphate
---
http://syngof.fr/wp-content/uploads/2016/04/2016-003-Biomedecine-Reco-AMP-et-Zika-.pdf
2016
false
false
false
France
French
guideline
Zika Virus Infection
france
fertility preservation
americas
directive counseling
mars
zika virus
adenosine monophosphate
gametes
directed tissue donation
occupational
fertility, nos
disease outbreaks
viruses
french
gift giving
recommendations, health planning
condom
epidemics
patient care management
germ cells
gift giving
health planning guidelines
epidemics
---
http://www.has-sante.fr/portail/jcms/c_2620141/fr/kengrexal
2016
false
false
false
France
French
treatment outcome
cangrelor
cangrelor
drug therapy, combination
adult
coronary artery disease
percutaneous coronary intervention
injections, intravenous
infusions, intravenous
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
myocardial infarction
embolism and thrombosis
aspirin
hemorrhage
cangrelor
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
receptors, purinergic P2Y12
evaluation of the transparency committee
Cangrelor Tetrasodium
Cangrelor Tetrasodium
angioplasty
emergency treatment
adenosine monophosphate
---
http://www.sudoc.fr/191002127
2016
false
true
false
France
French
dissertations, academic
restaurants
infertility
food services
fertility, nos
Physicians
medicine
infertility, nos
patient care management
medical
adenosine monophosphate
fertility
persons
---
https://www.ema.europa.eu/medicines/human/EPAR/Kengrexal
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
cangrelor
cangrelor
cangrelor
drug therapy, combination
adult
coronary artery disease
percutaneous coronary intervention
injections, intravenous
infusions, intravenous
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
platelet aggregation inhibitors
myocardial infarction
embolism and thrombosis
product surveillance, postmarketing
aspirin
hemorrhage
cangrelor
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
drug interactions
pregnancy
breast feeding
receptors, purinergic P2Y12
drug evaluation, preclinical
adenosine monophosphate
---
http://www.meddispar.fr/Medicaments/UROSIPHON-B-20/(type)/letter/(value)/U/(cip)/3400933642631
2012
France
drug information
adenosine monophosphate
soil
reproductive techniques, assisted
---
http://www.agence-biomedecine.fr/IMG/pdf/l-amp-a-risque-viral.pdf
2006
France
technical report
risk
adenosine monophosphate
reproductive techniques, assisted
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031937.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400360
2005
France
French
treatment outcome
venous insufficiency
hemorrhoids
adenosine monophosphate
other capillary stabilizing agents
administration, oral
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031953.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400376
2005
France
French
heptaminol adenylate
administration, oral
venous insufficiency
hemorrhoids
metrorrhagia
intrauterine devices
treatment outcome
heptaminol
adenosine monophosphate
evaluation of the transparency committee
---